Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Tohen

Showing results (101-110 of 260) with videos related to

Pageof 26
Sort By:
Journal of Clinical Psychopharmacology|November 14, 2009
Number needed to treat or harm analyses of olanzapine for maintenance treatment of bipolar disorderMauricio Tohen, Jennifer Sniadecki, Virginia K Sutton, et al.
Psychiatry and Clinical Neurosciences|January 15, 2014
Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysisHideaki Katagiri, Mauricio Tohen, David P McDonnell, et al.
International Journal of Bipolar Disorders|February 20, 2018
The association between mood state and chronobiological characteristics in bipolar I disorder: a naturalistic, variable cluster analysis-based studyRobert Gonzalez, Trisha Suppes, Jamie Zeitzer, et al.
BMC Psychiatry|May 16, 2013
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled studyHideaki Katagiri, Mauricio Tohen, David P McDonnell, et al.
Bipolar Disorders|March 27, 2003
Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar maniaK N Roy Chengappa, Robert W Baker, Lixin Shao, et al.
Journal of Child and Adolescent Psychopharmacology|October 12, 2013
Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophreniaDavid E Kemp, Christoph U Correll, Mauricio Tohen, et al.
Community Mental Health Journal|January 31, 2020
Methamphetamine Abuse Trends in Psychiatric Emergency Services: A Retrospective Analysis Using Big DataJeremy Miller, Robby Atala, Dusadee Sarangarm, et al.
Biological Psychiatry|November 25, 2006
Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matterIsabelle M Rosso, William D S Killgore, Christina M Cintron, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 25, 2012
Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depressionMauricio Tohen, David P McDonnell, Michael Case, et al.
The American Journal of Psychiatry|August 16, 2016
Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD StudyRodrigo Machado-Vieira, David A Luckenbaugh, Elizabeth D Ballard, et al.
Pageof 26

Showing results (101-110 of 260) with videos related to

Sort By:
Pageof 26
Journal of Clinical Psychopharmacology|November 14, 2009
Number needed to treat or harm analyses of olanzapine for maintenance treatment of bipolar disorderMauricio Tohen, Jennifer Sniadecki, Virginia K Sutton, et al.
Psychiatry and Clinical Neurosciences|January 15, 2014
Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysisHideaki Katagiri, Mauricio Tohen, David P McDonnell, et al.
International Journal of Bipolar Disorders|February 20, 2018
The association between mood state and chronobiological characteristics in bipolar I disorder: a naturalistic, variable cluster analysis-based studyRobert Gonzalez, Trisha Suppes, Jamie Zeitzer, et al.
BMC Psychiatry|May 16, 2013
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled studyHideaki Katagiri, Mauricio Tohen, David P McDonnell, et al.
Bipolar Disorders|March 27, 2003
Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar maniaK N Roy Chengappa, Robert W Baker, Lixin Shao, et al.
Journal of Child and Adolescent Psychopharmacology|October 12, 2013
Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophreniaDavid E Kemp, Christoph U Correll, Mauricio Tohen, et al.
Community Mental Health Journal|January 31, 2020
Methamphetamine Abuse Trends in Psychiatric Emergency Services: A Retrospective Analysis Using Big DataJeremy Miller, Robby Atala, Dusadee Sarangarm, et al.
Biological Psychiatry|November 25, 2006
Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matterIsabelle M Rosso, William D S Killgore, Christina M Cintron, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 25, 2012
Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depressionMauricio Tohen, David P McDonnell, Michael Case, et al.
The American Journal of Psychiatry|August 16, 2016
Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD StudyRodrigo Machado-Vieira, David A Luckenbaugh, Elizabeth D Ballard, et al.
Pageof 26